KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ardelyx (ARDX) EBT (2016 - 2026)

Ardelyx (ARDX) has disclosed EBT for 14 consecutive years, with -$37.6 million as the latest value for Q1 2026.

  • For Q1 2026, EBT rose 6.67% year-over-year to -$37.6 million; the TTM value through Mar 2026 reached -$57.9 million, down 9.83%, while the annual FY2025 figure was -$60.6 million, 55.98% down from the prior year.
  • EBT hit -$37.6 million in Q1 2026 for Ardelyx, down from -$400000.0 in the prior quarter.
  • Across five years, EBT topped out at $10.7 million in Q4 2022 and bottomed at -$40.3 million in Q1 2025.
  • Average EBT over 5 years is -$15.9 million, with a median of -$19.1 million recorded in 2025.
  • On a YoY basis, EBT climbed as much as 129.83% in 2023 and fell as far as 366.19% in 2023.
  • Ardelyx's EBT stood at $10.7 million in 2022, then tumbled by 366.19% to -$28.5 million in 2023, then soared by 116.44% to $4.7 million in 2024, then crashed by 108.55% to -$400000.0 in 2025, then crashed by 9299.25% to -$37.6 million in 2026.
  • According to Business Quant data, EBT over the past three periods came in at -$37.6 million, -$400000.0, and -$867000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.